Elliot Hershberg
1 appearance on the record.
computed by AI from the episodes · how this works → · full disclaimer →
Elliot Hershberg analyzes structural challenges in modern biotechnology and drug development. He focuses on the economic factors driving approval costs up to $2.5 billion per therapeutic.
4 supported 2 partly supported 0 contradicted 1 not yet assessed how the 7 claims stand · each chip opens the sources
7 assertions · 3 opinions · 1 insight · 1 disclosure · every statement was checked. The predictions and assertions are the 7 claims: statements the public record can support or contradict. 6 are resolved, 1 is not yet assessed. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.
The record, in short
What the tape says about how Elliot argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.
How they sound: speaking style how? →
250 words/min while actually speaking · 44 um and uh per 1k words
No argument clarity score for Elliot Hershberg: no usable question→answer exchanges on raw tape (a fair score needs 8+). We do not score a sample that small. Roundtable and news formats yield far fewer direct exchanges than interviews.
Measured by listening to the audio itself: 4,384 words across 1 episode of raw-level tape, transcribed verbatim with every um and uh kept, each one attributed only where the alignment onto our timed stream is unambiguous. These are measurements of speaking style. We do not rank them: across this corpus, fluency and argument quality are nearly uncorrelated (ρ≈0.2), and smooth talking does not signal clear thinking. How it's measured →
Everything Elliot Hershberg said on the a16z Podcast that made the record, most notable first. Filter by type, assessment or year in the ledger →
Appearances (1)
| Episode | Date | Speaking time |
|---|---|---|
| The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation | Nov 14, 2025 | 22m |